Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is a heterogeneous group of breast cancers characterized by their lack of estrogen receptors, progesterone receptors, and the HER2 receptor. They are more aggressive than other breast cancer subtypes, with a higher mean tumor size, higher tumor grade, the worst f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapdelaine, Abygail G., Sun, Gongqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452226/
https://www.ncbi.nlm.nih.gov/pubmed/37627272
http://dx.doi.org/10.3390/biom13081207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452226/
https://www.ncbi.nlm.nih.gov/pubmed/37627272
http://dx.doi.org/10.3390/biom13081207

Ejemplares similares